Can you tell us more about your grandfather?
Andreas: His name was Erwin Riedel and he was born in 1906. After the Second World War, he came home and began his life-long career with the company. He had two doctoral degrees, one in pharmacy and one in chemistry, and became head of the Scientific Department in Heidenheim. He was a co-author of one of the early HARTMANN publications, entitled: “Verbandstoff-Fibel: Herstellung, Beschaffenheit und Anwendung der Verbandstoffe” (“Dressing material primer: production, condition and application of dressings.”). He participated in the European Medical Encyclopedia, and was sent to Strasbourg by the Foreign Ministry to work on the chapter about wound dressings. He was part of the “Oberrat” – the council – as a scientist and industry representative, and though he retired at age 65 in 1971, he still had an office and continued to consult HARTMANN until 1978.
And his story continues with you?
Andreas: Yes, it continued on 20 years later with me starting in 1996 in Heidenheim. When the US business took off three years later, I was sent to Chicago, then when HARTMANN acquired Conco-Medical in 2001, I moved to Rock Hill, South Carolina. That is where I am today, working as Director of Corporate Accounts. I handle the large distribution channels in the United States and am still heavily involved in international sales. It has been quite the ride with many different job descriptions and experiences in sales and marketing!
So now that we know what you do, can we “talk shop” for a second? What are some of the trends you are seeing in the US healthcare sector?
Andreas: The aging population and advances in medicine will continue to increase the cost of healthcare. Both private and government insurance companies are working to slow down such cost increases by keeping reimbursement levels under control. Providers depend on reimbursement, yet they are also held accountable for outcomes and quality of care for the patient. So, they seek to take advantage of innovative new therapies, while at the same time trying to control costs. They are looking to the industry for savings and for ways of doing more with less.